Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11716929 | 0.98 | MAPT (0.37) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL4323037 | 0.86 | CYP2A6 (0.38) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL4320295 | 0.81 | CYP2A6 (0.38) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL21791780 | 0.80 | CA1 (0.38) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL10709647 | 0.80 | MAPT (0.47) | MAPTTRPV1ALDH1A1KDM4EMEN1 | |
| SCHEMBL220074 | 0.80 | MAPT (0.47) | CYP2A6MAPTCHRNA7ALDH1A1KDM4E | |
| SCHEMBL11718412 | 0.79 | MAPT (0.33) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL7469958 | 0.78 | MAPT (0.45) | CYP2A6MAPTCHRNA7ALDH1A1KDM4E | |
| SCHEMBL10603546 | 0.78 | GAA (0.42) | MAPTCA1CA2CA9APP | |
| SCHEMBL23149109 | 0.77 | ALDH1A1 (0.38) | CYP2A6MAPTCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024008909-A1 | INHIBITORS OF CORONAVIRUS | JANSSEN PHARMACEUTICA NV (BE) | 2024-01-11 | — | — | WO | disclosed |
| US-10472386-B2 | Bile acid derivatives as FXR agonists and methods of use thereof | ENANTA PHARMACEUTICALS, INC. (US) | 2019-11-12 | — | — | US | disclosed |
| EP-2731430-B1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2019-04-03 | — | — | EP | disclosed |
| EP-2731430-B1 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2019-04-03 | — | — | EP | disclosed |
| US-20180237471-A1 | BILE ACID DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF | ENANTA PHARMACEUTICALS, INC. | 2018-08-23 | — | — | US | disclosed |
| WO-2018152171-A1 | BILE ACID DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF | ENANTA PHARMACEUTICALS, INC. (US) | 2018-08-23 | — | — | WO | disclosed |
| US-9732109-B2 | Pesticidal compositions | DOW AGROSCIENCES LLC (US) | 2017-08-15 | — | — | US | disclosed |
| US-9604942-B2 | Preparation of haloalkoxyarylhydrazines and intermediates therefrom | DOW AGROSCIENCES LLC (US) | 2017-03-28 | — | — | US | disclosed |
| CN-103826452-B | Pesticidal compositions and processes related thereto | 陶氏益农公司 | 2017-02-01 | — | — | CN | disclosed |
| EP-2247603-B1 | PESTICIDAL COMPOSITIONS | DOW AGROSCIENCES LLC (US) | 2016-09-28 | — | — | EP | disclosed |
| US-4294964-A | IMMUNOSUPRESSIVE AGENTS | ELI LILLY AND COMPANY (US) | 1981-10-13 | — | — | US | disclosed |
| US-4224326-A | 2-ARYL-1H-PERIMIDINES | ELI LILLY AND COMPANY (US) | 1980-09-23 | — | — | US | disclosed |
| US-4194899-A | HERBICIDES, FUNGICIDES, PLANT GROWTH REGULATORS | ELI LILLY AND COMPANY (US) | 1980-03-25 | — | — | US | disclosed |
| EP-0002906-A2 | Novel perimidines, their preparation, formulations and use as immunosuppressives | ELI LILLY AND COMPANY (US) | 1979-07-11 | — | — | EP | disclosed |
| US-4110099-A | INHIBITOR FOR INTERNODEL GROWTH OF PLANTS | ELI LILLY AND COMPANY (US) | 1978-08-29 | — | — | US | disclosed |
| US-4043791-A | Method of regulating the growth of aquatic weeds with pyridine derivatives | ELI LILLY AND COMPANY (US) | 1977-08-23 | — | — | US | disclosed |
| US-RE29367-E | HERBICIDES, FUNGICIDES, 5-PYRIMIDINYL | ELI LILLY AND COMPANY (US) | 1977-08-23 | — | — | US | disclosed |
| US-4031119-A | LUBRICANTS, GREASES, SEALS | PONOMAREV ALEXEI IVANOVICH | 1977-06-21 | — | — | US | disclosed |
| US-4002628-A | HERBICIDES, PLANT FUNGICIDES, PLANT GROWTH REGULATORS | ELI LILLY AND COMPANY (US) | 1977-01-11 | — | — | US | disclosed |
| US-3967949-A | Fluoroalkoxyphenyl-substituted nitrogen heterocycles as plant stunting agents | ELI LILLY AND COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10472386-B2 | Bile acid derivatives as FXR agonists and methods of use thereof | NR1H4, GPBAR1, SLC10A1 | CYP2A6 213/4885MAPT 2382/4885CA1 2692/4885 |
| US-20180237471-A1 | BILE ACID DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF | NR1H4, GPBAR1, SLC10A1 | CYP2A6 213/4885MAPT 2382/4885CA1 2692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.